Procalcitonin for the diagnosis of sepsis in critically ill patients, focus on immunocompromised patients;La PCT pour diagnostiquer le sepsis en réanimation, focus sur le patient immunodéprimé

Reanimation

Volumn 17, Issue 3 SUPPL. 1, 2008, Pages 5-8

  Bele N ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN;

ARTICLE; CRITICAL ILLNESS; DIAGNOSTIC VALUE; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; LUNG LAVAGE; PATIENT MONITORING; PROGNOSIS; RESPIRATORY TRACT INFECTION; RESUSCITATION; SEPSIS;

EID: 46049108753     PISSN: 16240693     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1624-0693(08)72489-7     Document Type: Article

References (11)

1. Harbarth S., Holeckova K., Froidevaux C., et al. Diagnostic value of procalcitonin, interleukin-6 and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 164 (2001) 396-402
2. Christ-Crain M., Jaccard-Stolz D., Bingisser R., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
3. Christ-Crain M., Stolz D., Bingisser R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med 174 (2006) 84-93
4. Stolz D., Christ-Crain M., Bingisser R., et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 131 (2007) 9-19
5. Schüttrumpf S., Binder L., Hagemann T., et al. Procalcitonin : a useful discriminator between febrile conditions of different origin in hemato-oncological patients?. Ann Hematol 82 (2003) 98-103
6. Von Lilienfeld-Toal M., Dietrich M.P., Glasmacher A., et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies : procalcitonin and IL-6 are more reliable than C-reactive protein. Eur J Clin Microbiol Infect Dis 23 (2004) 539-544
7. Jimeno A., Garcia-Velasco A., del Val O., et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100 (2004) 2462-2469
8. Schuttrumpf S., Binder L., Hageman T., et al. Utility of procalcitonin concentration in the evaluation of patients with malignant diseases and elevated C-reactive protein plasma concentrations. Clin Infect Dis 43 (2006) 468-473
9. Gérard Y., Hober D., Assicot M., et al. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 35 (1997) 41-46
10. Schleicher G.K., Herbert V., Brink A., et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 25 (2005) 688-692
11. Stolz D., Stulz A., Müller B., et al. BAL neutrophils, serum procalcitonin and C-reactive protein to predict bacterial infection in the immunocompromised host. Chest 132 (2007) 504-514